Ann: HCV TRIAL UPDATE, page-16

Coolstocks, first of all calm down mate, its not the end of the world.
Second, Independent Data Safety Monitoring Board review after first patient in each cohort and between cohorts takes time.

Thirdly you will also note that they are looking at commencing recruitment of additional clinical trials sites, in addition to Duke and recently commissioned second site UCSD to speed it all up.

Also am i wrong in saying that after the next results come out it will validate safety?
Is that not a good thing?
Would that not push the SP up?